#ASTRO2014 - Impact of prior docetaxel, extent of disease, and prior bisphosphonates on hematologic safety of radium-223 dichloride from ALSYMPCA - Poster

SAN FRANCISCO, CA USA (UroToday.com) - Presented by J. M. Michalski,1 C. Parker,2 O. Sartor,3 N. J. Vogelzang,4 I. Haugen,5 S. Nilsson6 at the 56th Annual Meeting of the American Society for Radiation Oncology - September 14 - 17, 2014 - San Francisco, CA USA

michalski poster ASTRO 2014

Click HERE to listen to one of the authors, Oliver Sartor, MD, discuss this study

1Washington University School of Medicine, St Louis, MO, USA;
2The Royal Marsden NHS Foundation Trust and Institute of Cancer Research, Sutton, UK;
3Tulane Cancer Center, New Orleans, LA, USA;
4Comprehensive Cancer Centers of Nevada, Las Vegas, NV, USA;
5Algeta ASA (Bayer), Oslo, Norway;
6Karolinska University Hospital, Stockholm, Sweden

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe